Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Akanda Corp AKAN

Akanda Corp. is an international medical cannabis and wellness platform company. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United... see more

Recent & Breaking News (NDAQ:AKAN)

Akanda Corp. Announces Closing of the Sale of RPK

Newsfile April 11, 2024

Akanda Corp. Announces Canmart's Plans for Facebook and Instagram Social Shopping Technology Integration

Newsfile March 28, 2024

Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of the Cannabis Market

Newsfile March 28, 2024

Akanda Corp. Announces Closing of Underwritten Public Offering

Newsfile March 27, 2024

Akanda Corp. Announces Pricing of Underwritten Public Offering

Newsfile March 25, 2024

RETRANSMISSION: Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals

Newsfile March 1, 2024

Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals

Newsfile February 29, 2024

Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders

Newsfile February 20, 2024

Akanda Corp. Provides Update on Annual Meeting of its Shareholders

Newsfile February 20, 2024

Akanda Corp. Discusses Positive Trends in UK Cannabis Market

Newsfile February 13, 2024

Akanda Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Newsfile February 2, 2024

Akanda Corp. Provides Update on Scheduling Policy in US Aims to Be Among First International Movers in US Pending Approval

Newsfile February 2, 2024

Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Newsfile February 2, 2024

Akanda Corp. Entered into Non-Binding Letter of Intent for Sale of RPK

Newsfile February 1, 2024

Akanda Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Newsfile January 4, 2024

Akanda Corporation Announces CFO Appointment

Newsfile December 11, 2023

Akanda Corp. Announces Signing of Option to Develop Canadian THC and CBD Farming Facility

Business Wire September 20, 2023

Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Business Wire July 6, 2023

Akanda Corp. Announces Termination of Loan Agreement

Business Wire May 29, 2023

Akanda Corp. Announces Loan Agreement

Business Wire April 28, 2023